QUARTERLY RESULTS (UNAUDITED) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended																12 Months Ended
	Jun. 30, 2020		Mar. 31, 2020		Dec. 31, 2019		Sep. 30, 2019		Jun. 30, 2019		Mar. 31, 2019		Dec. 31, 2018		Sep. 30, 2018		Jun. 30, 2020		Jun. 30, 2019		Jun. 30, 2018
Net Sales	$ 17,698		$ 17,214		$ 18,240		$ 17,798		$ 17,094		$ 16,462		$ 17,438		$ 16,690		$ 70,950		$ 67,684		$ 66,832
Operating Income	$ 3,481		$ 3,453		$ 4,482		$ 4,290		$ (5,192)		$ 3,229		$ 3,896		$ 3,554		$ 15,706		$ 5,487		13,363
Gross Margin Percent of Net Sales	49.50%		49.40%		51.40%		51.00%		47.70%		48.80%		48.90%		49.20%		50.30%		48.60%
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest	$ 2,786		$ 2,957		$ 3,743		$ 3,617		$ (5,237)		$ 2,776		$ 3,216		$ 3,211		$ 13,103		$ 3,966
NET EARNINGS:
Net Income (Loss) Attributable to Parent	$ 2,800		$ 2,917		$ 3,717		$ 3,593		$ (5,241)		$ 2,745		$ 3,194		$ 3,199		$ 13,027	[1]	$ 3,897	[1]	$ 9,750	[1]
DILUTED NET EARNINGS PER COMMON SHARE
Earnings Per Share, Diluted	$ 1.07	[2]	$ 1.12	[2]	$ 1.41	[2]	$ 1.36	[2]	$ (2.12)	[2],[3]	$ 1.04	[2],[3]	$ 1.22	[2],[3]	$ 1.22	[2],[3]	$ 4.96	[2],[4],[5]	$ 1.43	[2],[3],[4],[5]	$ 3.67	[4],[5]

[1] Net earnings attributable to Procter & Gamble in fiscal 2019 was negatively impacted by the impairment charges of $8.3 billion related to Shave Care goodwill and Gillette indefinite-lived intangible assets.

[2] Diluted net earnings/(loss) per share is calculated on Net earnings/(loss) attributable to Procter & Gamble.

[3] Diluted net earnings/(loss) per share in each quarter is computed using the weighted average number of shares outstanding during that quarter while Diluted net earnings/(loss) per share for the full year is computed using the weighted average number of shares outstanding during the year.  In the quarter ended June 30, 2019, the Company reported a Net loss attributable to P&G, driven by the Shave Care impairment charges discussed in Note 4.  This caused certain of our equity instruments to be antidilutive for the full year (preferred shares) and for the quarter ended June 30, 2019 (preferred shares and equity awards). Because these securities were dilutive during the first three quarters of this fiscal year, the sum of the four quarters' Diluted net earnings/(loss) per share will not equal the full-year Diluted net earnings per common share.

[4] Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.

[5] Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.